IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
36 hedge funds and large institutions have $2.77M invested in ImmunoCellular Therapeutics, Ltd. in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$12.5K | |
| 2 | +$10.5K | |
| 3 | +$6.05K | |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
+$5.7K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$2.59K |
Top Sellers
| 1 | -$22.4K | |
| 2 | -$6.24K | |
| 3 | -$4K | |
| 4 |
CCC
Chelsea Counsel Company
Los Angeles,
California
|
-$514 |
| 5 |
Citigroup
New York
|
-$154 |